yf_tkr_HUM · 2026-10-23
Humana just posted its Q3 2026 scorecard and the headline is simple. Profit swung back to a solid quarter with basic earnings per share of 2.59 SEK on revenue of 2,595 million SEK. The share price, sitting at SEK70.40 into the release with a 7‑day return effectively flat, reflected a market still unsure about the story. The real tension is psychological. Traders are reacting to a healthcare operator that now earns a trailing P/E of 18.8x while carrying a thin 1.8% net margin and a history of...
Sector coverage: Healthcare · Healthcare Plans · Medical Devices
Read the original at yf_tkr_HUM ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。